Akut limfoid leukémia (ALL): vizsgálatok itt: Kína
169 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleComparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
- Where
- Hangzhou
- Életkor
- 14 év to 75 év
- People
- 81
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06361329 - Korai 1. fázisTaking peopleDonor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 15
- Run by
- Zhejiang University
See details and how to joinNCT06793241 - Korai 1. fázisTaking peopleThe Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
- Where
- Hefei, Wuhan
- Életkor
- 3 év to 70 év
- People
- 9
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06307600 - No phaseTaking peopleA Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
- Where
- Taiyuan
- People
- 45
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT06783816 - 2. fázisTaking peopleCAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
- Where
- Tianjin
- Életkor
- Up to 25 év
- People
- 100
- Run by
- Beijing Yongtai Ruike Biotechnology Company Ltd
See details and how to joinNCT06179524 - No phaseTaking peopleDolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
- Where
- Hefei
- Életkor
- 2 év to 17 év
- People
- 500
- Run by
- Anhui Provincial Children's Hospital
See details and how to joinNCT06756022 - 1. fázisTaking peopleCD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
- Where
- Guangzhou
- Életkor
- 1 év to 18 év
- People
- 10
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06752785 - 2. fázisTaking peopleVenetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 36
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06754267 - 2. fázisTaking peopleVHAG in Treating R/R T-ALL/LBL
- Where
- Hangzhou
- Életkor
- 14 év to 74 év
- People
- 50
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06742463 - 2. fázisTaking peopleBlinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
- Where
- Hangzhou
- Életkor
- 15 év to 59 év
- People
- 20
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06742515 - 1/2. fázisTaking peopleCD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
- Where
- Wuhan
- Életkor
- 3 év to 75 év
- People
- 80
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06735495 - 4. fázisCsak meghívásosExploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia
- Where
- Wuhan
- Életkor
- 1 nap to 7 év
- People
- 180
- Run by
- Yilin Zhao
See details and how to joinNCT06711679 - Korai 1. fázisTaking peopleAllogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
- Where
- Suzhou
- Életkor
- 14 év and over
- People
- 18
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06696833 - 2. fázisTaking peopleDecitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
- Where
- Suzhou
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06393985 - 1/2. fázisTaking peopleSequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
- Where
- Beijing
- Életkor
- 2 év to 90 év
- People
- 60
- Run by
- Essen Biotech
See details and how to joinNCT06420076 - 2. fázisTaking peopleCombination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
- Where
- Tianjin
- Életkor
- 16 év to 70 év
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06608732 - 3. fázisNot yet taking people in KínaBuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
- Where
- Suzhou
- Életkor
- 2 év to 55 év
- People
- 430
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06673459 - Korai 1. fázisTaking peopleSafety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
- Where
- Jinzhou
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- Tan Jie
See details and how to joinNCT06659653 - 1. fázisNot yet taking people in KínaClinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 24
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06641024 - Korai 1. fázisTaking peopleTargeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
- Where
- Hangzhou
- People
- 30
- Run by
- Zhejiang University
See details and how to joinNCT06633354 - 2. fázisTaking peopleBCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.
- Where
- Shanghai
- Életkor
- 18 év to 60 év
- People
- 206
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06598722 - 2/3. fázisTaking peopleEfficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
- Where
- Fuzhou, Hefei, Ningbo, Shanghai
- Életkor
- 1 hónap to 18 év
- People
- 90
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06607419 - 2. fázisTaking peopleAutologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
- Where
- Tianjin
- Életkor
- 18 év to 65 év
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06608342 - No phaseTaking peopleInaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
- Where
- Beijing, Chengdu, Guangzhou, Jinan, Shanghai, Tianjin, Wuhan, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Juventas Cell Therapy Ltd.
See details and how to joinNCT06450067 - Korai 1. fázisNot yet taking people in KínaHema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
- Where
- Suzhou
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06559644